UK regulators have approved nirogacestat as the first licensed drug for adults with progressive desmoid tumours.

The MHRA has strengthened addiction warnings for Z-drugs, benzodiazepines, and gabapentinoids after a review found risks of ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

Patients who buy illicit painkillers, erectile dysfunction pills and other unlicensed medicines on the black market are ...

The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s disease and ulcerative colitis (UC). Already used for plaque psoriasis and ...

As many people consider lifestyle changes at the start of the year, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is urging the public to make sure any weight-loss medicines they ...

As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review. The Medicines and Healthcare products ...